Skip to content

← All developments

Mississippi Legislature (healthcare bills) · March 16, 2026 · Primary source

MS HB 565: Health benefit plans and Medicaid; require to offer coverage for biomarker testing.

Score 66PRIMARYregulatoryState legislatureMS

Summary

Mississippi HB 565 has been approved by the Governor and requires health benefit plans and Medicaid in Mississippi to offer coverage for biomarker testing. The law adds Mississippi to a growing list of states mandating biomarker testing coverage, affecting both commercial insurers and the state Medicaid program.

What this may mean

Health benefit plans and Medicaid managed care organizations operating in Mississippi must now include coverage for biomarker testing in their benefit designs. Commercial insurers and Medicaid plans that exclude biomarker testing from covered services will need to update plan documents and utilization management criteria to comply. The law affects payers across the Mississippi market and has implications for oncology, genetic testing, and precision medicine service lines.

Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.

Related items